meta-analysis | Q815382 |
scholarly article | Q13442814 |
systematic review | Q1504425 |
P50 | author | Perminder Sachdev | Q7169326 |
Carole Dufouil | Q58275775 | ||
Lewis Kuller | Q88077314 | ||
Sudha Seshadri | Q28516588 | ||
Lindsay A. Farrer | Q37380266 | ||
Kathryn L. Lunetta | Q37630755 | ||
Alexa Beiser | Q42561271 | ||
Philip A Wolf | Q42561276 | ||
Rhoda Au | Q43127298 | ||
Anita L DeStefano | Q47502953 | ||
Christophe Tzourio | Q56816583 | ||
P2093 | author name string | Karen A Mather | |
Wei Wen | |||
Seung Hoan Choi | |||
Bernard Mazoyer | |||
Naftali Raz | |||
José Rafael Romero | |||
Stéphanie Debette | |||
Sabrina Schilling | |||
Peter Høgh | |||
Yi-Cheng Zhu | |||
Charles D DeCarli | |||
P2860 | cites work | Changes in Vascular Risk Factors from Midlife to Late Life and White Matter Lesions: A 20-Year Follow-Up Study | Q59542855 |
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria | Q73550740 | ||
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease | Q28238269 | ||
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium | Q28252389 | ||
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study | Q30425779 | ||
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage | Q30429407 | ||
Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? | Q30775068 | ||
Silent brain infarcts: a systematic review | Q31116425 | ||
Cerebral microbleeds: a guide to detection and interpretation | Q33401999 | ||
Cadasil | Q33470786 | ||
Low levels of high density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases. | Q33573845 | ||
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis | Q33641052 | ||
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study | Q33762168 | ||
MRI Markers of Small Vessel Disease in Lobar and Deep Hemispheric Intracerebral Hemorrhage | Q33855436 | ||
Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium | Q34071362 | ||
Genetic variation and neuroimaging measures in Alzheimer disease | Q34208735 | ||
Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants | Q34213287 | ||
Cerebral amyloid angiopathy and vessel dysfunction | Q34568781 | ||
Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase | Q34636326 | ||
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium | Q35065065 | ||
Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease. | Q35456894 | ||
Does APO epsilon4 correlate with MRI changes in Alzheimer's disease? | Q35572157 | ||
Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. | Q36356533 | ||
Brain tissue volumes by APOE genotype and leisure activity-the AGES-Reykjavik Study | Q36767483 | ||
Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging | Q36856068 | ||
Neuroimaging and APOE genotype: a systematic qualitative review | Q36958554 | ||
The genetic architecture of intracerebral hemorrhage | Q37158275 | ||
Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. | Q37465916 | ||
Review: sporadic cerebral amyloid angiopathy | Q37800132 | ||
Apolipoprotein E in Alzheimer's disease and other neurological disorders | Q37846932 | ||
Genetic associations with brain microbleeds: Systematic review and meta-analyses. | Q37895813 | ||
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition | Q43275099 | ||
Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population | Q44017324 | ||
Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis | Q44756500 | ||
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study | Q44904997 | ||
APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI. | Q46794966 | ||
Sex differences in the causes and consequences of white matter hyperintensities | Q46939985 | ||
Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. | Q47367180 | ||
Interaction between hypertension, apoE, and cerebral white matter lesions | Q47832284 | ||
The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years | Q48124401 | ||
Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study | Q48143642 | ||
Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study | Q48148055 | ||
Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects | Q48187762 | ||
The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities | Q48233581 | ||
Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. | Q48261974 | ||
Apolipoprotein E epsilon4 allele is associated with the volume of white matter changes in patients with lacunar infarcts | Q48397851 | ||
Apolipoprotein E genotype is related to progression of white matter lesion load | Q48498237 | ||
Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study | Q48530028 | ||
Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. | Q48647143 | ||
Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population | Q48667530 | ||
Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression | Q48675144 | ||
Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study | Q48717937 | ||
Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates | Q48868567 | ||
Prevalence and severity of cerebral amyloid angiopathy: a population-based study on very elderly Finns (Vantaa 85+). | Q48900176 | ||
Prevalence and severity of microbleeds in a memory clinic setting. | Q51917851 | ||
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. | Q53229521 | ||
Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. | Q53235396 | ||
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location | Q57267148 | ||
Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population | Q57621266 | ||
Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study | Q57621271 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meta-analysis | Q815382 |
systematic review | Q1504425 | ||
cerebrovascular disease | Q3010352 | ||
P304 | page(s) | 292-300 | |
P577 | publication date | 2013-07-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis | |
P478 | volume | 81 |
Q47697118 | A population neuroscience approach to the study of cerebral small vessel disease in mid- and late-life: an Invited Review |
Q46228269 | APOE Genotypes Associate With Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND. |
Q47123978 | APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease |
Q36593238 | APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL |
Q34613047 | APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role? |
Q90424400 | APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia |
Q41449908 | APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds |
Q30825729 | Advances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging |
Q48148385 | Affect of APOE on information processing speed in non-demented elderly population: a preliminary structural MRI study |
Q37671476 | Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936. |
Q49156452 | ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy. |
Q92322562 | Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies |
Q90259358 | Apolipoprotein E promoter genotypes are not associated with white matter hyperintensity development in high-altitude careers |
Q50035045 | Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response |
Q36707857 | Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer |
Q58719840 | Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function |
Q59050338 | Are the effects ofAPOEϵ4 on cognitive function in nonclinical populations age- and gender-dependent? |
Q34116095 | Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme |
Q38748717 | Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study |
Q47105304 | Background and distribution of lobar microbleeds in cognitive dysfunction. |
Q26771852 | Cerebrovascular disease in ageing and Alzheimer's disease |
Q91583670 | Differential Impact of Plasma Homocysteine Levels on the Periventricular and Subcortical White Matter Hyperintensities on the Brain |
Q35203009 | Diffuse axonal injury at ultra-high field MRI |
Q60949811 | Effects of Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease |
Q41719695 | Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation |
Q57784857 | Evaluating apolipoprotein E genotype status and neuroprotective effects against white matter hyperintensity development in high-altitude careers |
Q50134655 | Gamma-Glutamyltransferase (GGT) as a biomarker of cognitive decline at the end of life: contrasting age and time to death trajectories |
Q61807445 | Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting |
Q62477928 | Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms |
Q28076438 | Genetic susceptibility to cerebrovascular disease |
Q50207666 | Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study. |
Q38931742 | Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients |
Q37715160 | Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association |
Q54974138 | Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology? |
Q36827380 | Interarm differences in systolic blood pressure and the risk of dementia and subclinical brain injury |
Q34019193 | Is Alzheimer's disease a systemic disease? |
Q37652814 | Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes. |
Q64103449 | Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts |
Q35739678 | Microstructural White Matter Properties Mediate the Association between APOE and Perceptual Speed in Very Old Persons without Dementia |
Q61445233 | Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study |
Q33689543 | Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study. |
Q88816335 | Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau |
Q36686478 | Sleep Disordered Breathing and White Matter Hyperintensities in Community-Dwelling Elders. |
Q61443837 | Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort |
Q39272772 | Sydney Memory and Ageing Study: an epidemiological cohort study of brain ageing and dementia |
Q26777958 | The Role of Sleep and Sleep Disorders in the Development, Diagnosis, and Management of Neurocognitive Disorders |
Q92744517 | The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population |
Q92252120 | The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE) |
Q36813704 | The role of APOE in cerebrovascular dysfunction |
Q38206263 | The role of apolipoprotein E in neurodegeneration and cardiovascular disease |
Q36731049 | The role of cerebrovascular disease when there is concomitant Alzheimer disease |
Q89470931 | Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease |
Q35834489 | Unraveling the potential co-contributions of cerebral small vessel vasculopathy to the pathogenesis of Alzheimer's dementia |
Q93132224 | Vascular Health is Associated with Amyloid-β in Cognitively Normal Older Adults |
Q91504592 | White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants |